US Patent 8003640 Organic compounds
Patent 8003640 was granted and assigned to Novartis on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+341 characters)
Article
Patent abstract
The present invention relates to compounds of the general formula (I) and the salts thereof, preferably the pharmaceutically acceptable salts thereof; in which in which R1 has the meaning explained in the description, a process for their preparation and the use of these compounds as medicines, especially as renin inhibitors.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08003640 Organic compounds US Patent 8003640 Organic compounds
Infobox
Patent Number
0800364000
Patent Number
800364000
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080036400
Date of Patent
August 23, 2011
0Patent Application Number
127451000
Date Filed
December 4, 2008
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080036400
Date of Patent
August 23, 2011
0Patent Application Number
127451000
Date Filed
December 4, 2008
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08003640 Organic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08003640
Date of patent
August 23, 2011
Patent application number
12745100
Date Filed
December 4, 2008
Patent primary examiner
Find more entities like US Patent 8003640 Organic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
